[Fracture prevention and GH replacement therapy].
Sugimoto
Toshitsugu
T
Department of Endocrinology, Metabolism and Hematological Oncology, Shimane University School of Medicine.
D000818:Animals; D016723:Bone Remodeling; D015195:Drug Design; D005598:Fractures, Spontaneous / Q000503:physiopathology / Q000517:prevention & control*; D020249:Hormone Replacement Therapy; D019382:Human Growth Hormone / Q000172:deficiency / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000378:metabolism; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D010012:Osteogenesis; D010024:Osteoporosis / Q000188:drug therapy* / Q000503:physiopathology
D018972:Insulin-Like Growth Factor Binding Protein 3; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I